Elevated Plasma Renin Activity Predicts Adverse Outcome in Chronic Heart Failure, Independently of Pharmacologic Therapy: Data From the Valsartan Heart Failure Trial (Val-HeFT)

Serge Masson; Scott D. Solomon; Laura Angelici; Roberto Latini; Inder S. Anand; Margaret F. Prescott; Aldo Maggioni; Gianni Tognoni; Jay N. Cohn

doi:10.1016/j.cardfail.2010.06.417

Elevated Plasma Renin Activity Predicts Adverse Outcome in Chronic Heart Failure, Independently of Pharmacologic Therapy: Data From the Valsartan Heart Failure Trial (Val-HeFT) — Serge Masson (2010) | RDL Network

Back

Home
Publications
Elevated Plasma Renin Activity Predicts Adverse Outcome in Chronic Heart Failure, Independently of Pharmacologic Therapy: Data From the Valsartan Heart Failure Trial (Val-HeFT)

Shared by

Aldo Maggioni

Elevated Plasma Renin Activity Predicts Adverse Outcome in Chronic Heart Failure, Independently of Pharmacologic Therapy: Data From the Valsartan Heart Failure Trial (Val-HeFT)

Article 2010 en

Authors

SM
Serge Masson
SS
Scott D. Solomon
LA
Laura Angelici

Discussion(0)

No comments yet. Be the first to comment.

Publication Info

DOI: 10.1016/j.cardfail.2010.06.417
Year: 2010
Published: —
Language: en

Article Details

Volume: 16
Issue: 12
Link Of The Paper: https://doi.org/10.1016/j.cardfail.2010.06.417

Timeline

Related publications

Article2005

Valsartan Reduces the Incidence of Atrial Fibrillation in Patients With Heart Failure: Results From the Valsartan Heart Failure Trial (Val-HeFT)

Aldo Maggioni, Roberto Latini, Peter E. Carson

Article2005

Valsartan reduces the incidence of atrial fibrillation in patients with heart failure: Results from the Valsartan Heart Failure Trial (Val-HeFT)

Aldo Maggioni, Roberto Latini, Peter E. Carson, Steven Singh, Simona Barlera, Robert Glazer, Serge Masson, E Cerè, Gianni Tognoni, Jay N. Cohn

Article2003

Valsartan reduces the incidence of atrial fibrillation in the patients with heart failure in the Val-HeFT Trial

Aldo Maggioni

Article2004

Effect of Valsartan Added to Background ACE Inhibitor Therapy in Patients with Heart Failure: Results from Val-HeFT

Henry Krum, Peter E. Carson, Csaba Farsang, Aldo Maggioni, Robert Glazer, Nora Aknay, YannTong Chiang, Jay N. Cohn

Article2007

Clinical, Neurohormonal, and Inflammatory Markers and Overall Prognostic Role of Chronic Obstructive Pulmonary Disease in Patients With Heart Failure: Data From the Val-HeFT Heart Failure Trial

Lidia Staszewsky, Maylene Wong, Serge Masson, Simona Barlera, Elisa Carretta, Aldo Maggioni, Inder S. Anand, Jay N. Cohn, Gianni Tognoni, Roberto Latini

Created:

June 19, 2026